Overexpression of SMAD4-209 in malignant cell lines would be of benefit for exploring its possible anti-tumor effect, while overexpression of SMAD4-213 in non-malignant cell lines would confirm its tumor-promoting role and both research directions would elucidate possible mechanism underlying those effects. This evidence concerns the gene SMAD4 and neoplasm.